Celsius Holdings reports Q1 EPS 40c, consensus 20c 16:20 CELH Reports Q1 revenue $260M,… OMG can you imagine what those MAY 100's options are going for! #shouldofheld
Airbnb sees Q2 adjusted EBITDA 'similar to' Q2 last year on nominal basis 16:10 ABNB lol- in other words....
I bought the first bunch of CVNA $11 mays for $.55-$.70 and $.80-$1 for the $10c CELH calls won’t double, the CVNA $10c hit $3.70 and $11c $2.90. Is CELH going to go from $.60 to $2.90?
That probably buys like one cannon. So as of 4/25 about 22% of Affirm's float was short. It was $10 then, so it squeezed (at the high today) about 21% since then. In the last two days about 45M shares have traded, so I'd imagine quite a few of those were shorts panicking. There was a total of about 47M shares sold short. One of two things will happen tomorrow. It'll either drop hard and fast from this AH's close of $11.32, probably to the $10.40 level, or it will spike up out of the gate to around $12.75 and then slowly climb if another squeeze is to be orchestrated. C3AI pulled this trick off last Q. Look where it's at now. $25 to a high of $35 on the spike, now $19. My opinion, with over 217M shares in the float, and about 80% institutional ownership, the latter is doubtful unless there's collusion between a few of the really big shareholders. But we'll see. There's no way a money losing company like this can sport an enterprise value of $6.6B.... I mean would anyone here (in theory) buy this business? I wouldn't. Why would you when you can get 4% in treasuries. Why would you buy a business that is losing and burning cash... with no other guidance except bumping the annual revenue. Show me the profit. When the dust settles and any potential squeeze is over... $8/share is being generous. jmho
This risk was not worth it! I made the mistake of buying SBUX July calls not realizing my footing(Earnings that day!), what a moron I am! Paid $4.75 ave down to $1.75 and sold $1.30.
A CHANGE IN TONE- Reading through each days analyst actions is a bit groundhog day it takes an abnormality to get my attention. The routine is.. well routine. Today there was a change in tone- more negative. It's subtle and you have to really have a feeling for this but it's there--- a Change in Tone.
--Cepton reports Q1 EPS (7c), consensus (10c) 17:05 CPTN --Guardant Health raises FY23 revenue view to $535M-$545M, consensus $533.48M » 17:06 GH --Azek CEO Singh sells 40,000 class A common shares » 19:11 AZEK --Dice Therapeutics director sells $3.24M in common stock 19:29 DICE --Oculis initiated with a Buy at Pareto 04:47 OCS --Dutch Bros downgraded on traffic challenges at TD Cowen 05:39 BROS --Vontier price target raised to $34 from $31 at Barclays » 05:56 VNT --Tabula Rasa HealthCare upgraded to Outperform from Market Perform at SVB Securities » 06:05 TRHC --LifeStance sees Q2 revenue $250M-$260M, consensus $250.46M » 06:11 LFST --Quotient Technology upgraded to Buy from Hold at Craig-Hallum 06:23 QUOT --Revance price target raised to $48 from $42 at H.C. Wainwright 06:24 RVNC --Natera price target raised to $70 from $65 at Credit Suisse » 06:53 NTRA
Microvast Holdings (MVST) We’ll start with Microvast Holdings, a leader in lithium-ion battery tech. The company’s advanced battery solutions are designed to power a wide range of electric vehicles, from small passenger cars to heavy-duty trucks and buses. Additionally, the company offers a comprehensive suite of services to support its customers, including battery system design and integration, testing and validation, and after-sales support. The firm also has a global reach, with manufacturing operations in China, as well as facilities in Germany and the U.S. The company will report Q1 earnings today after the close, but we can hark back to the Q4 and full-year 2022 report to get a picture of Microvast’s operations. In the quarter, revenue fell by 3% year-over-year to $64.8 million, although it should be noted that for the full-year, revenue reached $204.5 million, a 35% improvement on the $152 million generated in 2021. In Q4, the company delivered a non-GAAP adjusted net loss of $15.9 million, also bettering the loss of $33.4 million in the same period a year ago. Nevertheless, loss making firms have been out of favor in the high inflation and rising interest rate environment and that has been reflected in the stock’s poor performance; the shares have shed 66% over the past year. However, they are now at such a low level that H.C. Wainwright analyst Amit Dayal believes they present a “compelling entry point.” In the year ahead, the 5-star analyst thinks the stock should outperform its peers. This forecast is supported by: “(1) accelerating sales that should push margins to improve from 4.4% currently to 18.4% during the next two years; (2) a healthy balance sheet with $327.7M in cash that should be sufficient to cover planned capacity expansion and growth investment needs over the next 12-18 months; (3) capacity expansion plan in the U.S. and China, when fully utilized is expected to translate into an additional revenue potential of $1B; (4) solid manufacturing and distribution presence established in the U.S., allowing the company to benefit from grants and incentives stipulated under the IRA; (5) a relatively unique business model that allows for flexibility in meeting supply chain challenges better than some of its competitors; (6) a very healthy backlog of $410.5M…; and (7) significant industry runway with multi-billion addressable opportunities associated with the electrification trend.” That’s a long list that forms the basis of Dayal’s Buy rating on MVST. With shares trading at $1.19, the top analyst gives the stock an $8 price target, implying a huge 572%. Microvast seems to have slipped under most analysts’ radar; the stock’s Moderate Buy consensus is based on just two recent ratings – but both are Buys. Currently, Microvast shares trade at $1.14, while the average price target is $8, practically the same as Dayal’s
Dutch Bros is looking like a compelling short. If it stabilizes a bit $31 or so I see some troubles ahead. $29, $27 roller coaster after that.... BROS Dutch Bros Inc. $32.450.18 (+0.56%)4:00 PM 05/09/23 NYSE | $USD | Pre-Market: $29.86 -2.59 (-7.98%) <-----